Subscribe
Alistair Blair discovers that companies that don't splurge huge sums on top employees' salaries deliver the greatest gains to shareholders
AstraZeneca hasn't exactly set the world alight recently. But that's not stopped its chief executive from earning huge sums
Strange hedge fund champions shareholder committees
Goldman Sachs is not in a good place
A new look for an old idea
How markets and managers created a financial incentive bubble to justify ever-higher pay
A good campaign started in an unlikely place
Classic customers' yachts stuff
A bad year caps a bad decade for over-rated hedge funds
Have chief executives finally overcome our sense of fairness?
